AsortinoBeta
AbbVie Inc. logo

ABBVAbbVie Inc.

NYSEStockHealthcareDrug Manufacturers - General🇺🇸 United StatesISIN US00287Y1091abbvie.com
$256.461.44%
NYSE · at close Sep 4, 2026
Tokenized by
Backed Finance logoReality logoOndo Finance logoDinari Inc. logo
4 issuersOn
Solana logoEthereum logoArbitrum One logoTON logo
15 chains

Chart data are delayed by 15 minutes.

1D1.44%
1M+5.19%
3M+14.01%
1Y+20.40%
3Y+73.05%
5Y+129.76%

Main metrics

$453.19B
$278.84K<0.01% of mkt cap
72.45
$3.54
2.66%
4.9M
0.28
$190.7552-week range$267.47

About ABBV

AbbVie Inc. is a global biopharmaceutical company that develops, manufactures, and commercializes medicines and therapies for complex and serious diseases. AbbVie focuses on major therapeutic areas including immunology, oncology, neuroscience, eye care, aesthetics, and virology, serving patients with chronic autoimmune conditions, blood cancers, inflammatory disorders, and other specialized medical needs. The company’s portfolio includes branded prescription medicines and advanced therapies distributed through physicians, wholesalers, specialty pharmacies, healthcare facilities, and other healthcare channels. AbbVie also supports contract manufacturing services for selected biologics and pharmaceutical processes. Headquartered in North Chicago, Illinois, AbbVie operates as a research-driven healthcare business with a broad international footprint and a strong role in specialty medicine markets.

Similar products

Amgen Inc. logo
AMGNNASDAQ
$437.231.55%
Amgen Inc.
Ondo Finance logoBacked Finance logoReality logo
4 issuers · 14 chains
Biogen Inc. logo
BIIBNASDAQ
$220.831.64%
Biogen Inc.
Backed Finance logoReality logoDinari Inc. logo
3 issuers · 13 chains
Bristol-Myers Squibb Company logo
BMYNYSE
$66.821.87%
Bristol-Myers Squibb Company
Backed Finance logoReality logoDinari Inc. logo
3 issuers · 14 chains
Gilead Sciences, Inc. logo
GILDNASDAQ
$151.000.15%
Gilead Sciences, Inc.
Backed Finance logoReality logoDinari Inc. logo
3 issuers · 14 chains